Tuberculosis News and Research

Latest Tuberculosis News and Research

Patient's own bone-marrow stromal cells could treat multi-drug resistant TB

Findings of a preliminary study published in The Lancet Respiratory Medicine suggest that a patient’s own bone-marrow stromal (stem) cells could be used to treat multidrug-resistant (MDR) and extensively-drug (XDR) tuberculosis.

10 Jan 2014

AHF opens new Men's Wellness Center in Brooklyn in partnership with GMAD

AIDS Healthcare Foundation will open its newest Men's Wellness Center in Brooklyn on Wednesday in partnership with local nonprofit Gay Men of African Descent.

8 Jan 2014

Surgeons develop iPad app to capture trauma patient data in low medical resource environment

Electronic health records have become standard practice throughout hospitals in North America, but in countries with fewer resources many front-line clinicians are still collecting data on paper, if they are collecting it at all. But now, surgeons from Vancouver, British Columbia, have developed a way for their peers at a Level I trauma center in South Africa to accurately collect and analyze trauma care data via an iPad app. The study is published in the January issue of the Journal of the American College of Surgeons.

2 Jan 2014

EMA accepts Otsuka's marketing authorisation application for tolvaptan for treatment of ADPKD

Otsuka Pharmaceutical Co., Ltd. announced today that the European Medicines Agency (EMA) has accepted the submission of a marketing authorisation application (MAA) for the potential approval of tolvaptan for the treatment of autosomal dominant polycystic kidney disease (ADPKD).

27 Dec 2013

New tools for neglected diseases: an interview with Dr. BT Slingsby, CEO, GHIT Fund

Nearly 3.3 billion people, a little less than half of our world’s population, are at risk of malaria, TB and what we call “neglected tropical diseases”—diseases caused by worms, parasites, viruses and bacteria like Chagas disease, river blindness, elephantiasis, sleeping sickness, etc.

24 Dec 2013

Rutgers New Jersey Medical School's David Perlin explains how fungal infections can become deadly

Ask someone what the term 'fungus' brings to mind, and chances are it will be an image of something that smells or looks disgusting. Ask David Perlin, executive director of the Public Health Research Institute at Rutgers New Jersey Medical School, and the response will be far more somber - because he knows how deadly fungi can be.

24 Dec 2013

ATS, Springer to collaborate on book series, Respiratory Medicine

Springer and the American Thoracic Society (ATS) have entered into a partnership to collaborate on the book series Respiratory Medicine.

20 Dec 2013

TB-causing bacteria appear to mask their identity to avoid recognition by infection-killing cells

TB-causing bacteria appear to mask their identity to avoid recognition by infection-killing cells in the upper airways. The bacteria call up more permissive white blood cells in the deeper regions of the lungs and hitch a ride inside them to get into the host's body.

20 Dec 2013

BCG vaccine highly protective against pulmonary TB: Study

The BCG vaccine has been found to be more effective against the most common form of tuberculosis than previously thought, according to a new study in Clinical Infectious Diseases.

20 Dec 2013

Investigators, CTUs chosen to lead five HIV/AIDS clinical trials networks through 2021

Principal investigators and clinical trials units have been chosen to lead and conduct the research of five HIV/AIDS clinical trials networks through 2021. The effort is directed and funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. Total funding for the networks' leadership and the CTUs is expected to reach $225 million in 2014, the first year of operation.

17 Dec 2013

BWH receives $140M grant from NIAID to support ongoing research led by AIDS Clinical Trial Group

The National Institute of Allergy and Infectious Diseases has awarded two seven-year grants to Brigham and Women's Hospital to fund the AIDS Clinical Trial Group Network.

16 Dec 2013

Janssen receives complete response letter for canagliflozin/metformin FDC therapy for type 2 diabetes

Janssen Research & Development, LLC (Janssen) today announced it has received from the U.S. Food and Drug Administration (FDA) a complete response letter regarding its New Drug Application (NDA) for a fixed-dose combination (FDC) of canagliflozin and immediate-release metformin to treat adults with type 2 diabetes.

16 Dec 2013

Pregnant women, infants should avoid unpasteurized milk products, urge pediatricians

Pregnant women, infants and young children should avoid raw or unpasteurized milk and milk products and only consume pasteurized products, according to a new policy statement from the American Academy of Pediatrics.

16 Dec 2013

Findings could point the way to new vaccines to prevent Mycobacterium tuberculosis

The lung lesions in an individual infected with tuberculosis are surprisingly variable and independent of each other, despite whether the patient has clinically active or latent disease, according to a new animal study led by researchers at the University of Pittsburgh School of Medicine. The findings, published online today in Nature Medicine, could point the way to new vaccines to prevent the hard-to-treat infection.

16 Dec 2013

Viewpoints: Problems with the 'doc fix;' a lame budget deal; concerns about changes in doctor training

Imagine if a provision in ObamaCare allowed Health and Human Services Secretary Kathleen Sebelius to dictate directly to doctors which services they could and could not provide their patients-;what individual tests they could conduct, which treatments they could offer, and medicines they could prescribe.

13 Dec 2013

WHO hands over management of world's largest public collection of TB strains to ITM in Antwerp

The World Health Organisation handed over the management of the world's largest public collection of tuberculosis strains to the Institute of Tropical Medicine in Antwerp. These TB-strains play a key role in supporting scientific research into infectious diseases, particularly towards a better understanding of the TB bacterium's drug resistance.

13 Dec 2013

UCSF receives $15M grant to help three dozen countries eliminate malaria

UC San Francisco's Global Health Group has received a $15 million grant from the Bill & Melinda Gates Foundation for a pioneering effort to help nearly three dozen countries eliminate malaria within their borders.

13 Dec 2013

Results-Based Financing for Health can get 20% more health care with same funds

Countries and major donors are changing the way they finance maternal and child, malaria, tuberculosis and HIV/AIDS health programs in low-income countries to increase their impact.

11 Dec 2013

Otsuka, Lundbeck to develop investigational vaccine candidate for Alzheimer's disease

H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that they will further expand their collaboration to include the development of Lu AF20513, an investigational vaccine candidate for Alzheimer's disease.

11 Dec 2013

Study finds large degree of genetic variation amongst M. tuberculosis in humans in Zambia

In Zambia, the incidence of all forms of human tuberculosis is estimated to be 444 per 100,000. There is also a high incidence of HIV and AIDS in the country. In the Kafue area, a high incidence of Mycobacterium bovis in both cattle and the Kafue lechwe antilope has been detected. This bacterium can infect humans and has been found in humans in the studied region of Namwala. Mycobacterium tuberculosis, which is the main cause of human tuberculosis, has also been detected in cattle in this region.

10 Dec 2013

Tuberculosis News and Research

Latest Tuberculosis News and Research

Patient's own bone-marrow stromal cells could treat multi-drug resistant TB

AHF opens new Men's Wellness Center in Brooklyn in partnership with GMAD

Surgeons develop iPad app to capture trauma patient data in low medical resource environment

EMA accepts Otsuka's marketing authorisation application for tolvaptan for treatment of ADPKD

New tools for neglected diseases: an interview with Dr. BT Slingsby, CEO, GHIT Fund

Rutgers New Jersey Medical School's David Perlin explains how fungal infections can become deadly

ATS, Springer to collaborate on book series, Respiratory Medicine

TB-causing bacteria appear to mask their identity to avoid recognition by infection-killing cells

BCG vaccine highly protective against pulmonary TB: Study

Investigators, CTUs chosen to lead five HIV/AIDS clinical trials networks through 2021

BWH receives $140M grant from NIAID to support ongoing research led by AIDS Clinical Trial Group

Janssen receives complete response letter for canagliflozin/metformin FDC therapy for type 2 diabetes

Pregnant women, infants should avoid unpasteurized milk products, urge pediatricians

Findings could point the way to new vaccines to prevent Mycobacterium tuberculosis

Viewpoints: Problems with the 'doc fix;' a lame budget deal; concerns about changes in doctor training

WHO hands over management of world's largest public collection of TB strains to ITM in Antwerp

UCSF receives $15M grant to help three dozen countries eliminate malaria

Results-Based Financing for Health can get 20% more health care with same funds

Otsuka, Lundbeck to develop investigational vaccine candidate for Alzheimer's disease

Study finds large degree of genetic variation amongst M. tuberculosis in humans in Zambia

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in